• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性肾损伤患者的急性腹膜透析

Acute Peritoneal Dialysis in Patients with Acute Kidney Injury.

作者信息

Cho Seong, Lee Yu-Ji, Kim Sung-Rok

机构信息

Department of Internal Medicine, Division of Nephrology, Samsung Changwon Hospital, The Sungkyunkwan University School of Medicine, Changwon, Korea

Department of Internal Medicine, Division of Nephrology, Samsung Changwon Hospital, The Sungkyunkwan University School of Medicine, Changwon, Korea.

出版信息

Perit Dial Int. 2017 Sep-Oct;37(5):529-534. doi: 10.3747/pdi.2016.00264. Epub 2017 Mar 27.

DOI:10.3747/pdi.2016.00264
PMID:28348102
Abstract

BACKGROUND

The purpose of this study was to evaluate the efficacy, complications, and mortality rate associated with acute peritoneal dialysis (PD) in patients with acute kidney injury (AKI).

METHODS

A total of 75 patients who were treated at Samsung Changwon Hospital between February 2005 and March 2016 were included in the study sample. The outcomes included in-hospital survival, renal recovery, metabolic and fluid control rates, and technical success rates.

RESULTS

Refractory heart failure was the most frequent cause of acute PD (49.3%), followed by hepatic failure (20.0%), septic shock (14.7%), acute pancreatitis (9.3%), and unknown causes (6.7%). The hospital survival of patients in the acute PD was 48.0%. Etiologies of acute kidney injury (AKI) (refractory heart failure, acute pancreatitis compared with hepatic failure, septic shock or miscellaneous causes), use of inotropes, use of a ventilator, and simplified acute physiology score (SAPS) II were associated with survival differences. Maintenance dialysis required after survival was high (80.1% [29/36]) due to AKI etiologies (heart or hepatic failures). Metabolic and fluid control rates were 77.3%. The technical success rate for acute PD was 93.3%.

CONCLUSION

Acute PD remains a suitable treatment modality for patients with AKI in the era of continuous renal replacement therapy (CRRT). Nearly all patients who require dialysis can be dialyzed with acute PD without mechanical difficulties. This is particularly true in patients with refractory heart failure and acute pancreatitis who had a weak requirement for inotropes.

摘要

背景

本研究旨在评估急性肾损伤(AKI)患者进行急性腹膜透析(PD)的疗效、并发症及死亡率。

方法

研究样本纳入了2005年2月至2016年3月在三星昌原医院接受治疗的75例患者。观察指标包括院内生存率、肾功能恢复情况、代谢及液体控制率以及技术成功率。

结果

难治性心力衰竭是急性腹膜透析最常见的病因(49.3%),其次是肝衰竭(20.0%)、感染性休克(14.7%)、急性胰腺炎(9.3%)及病因不明(6.7%)。急性腹膜透析患者的院内生存率为48.0%。急性肾损伤的病因(难治性心力衰竭、急性胰腺炎与肝衰竭、感染性休克或其他病因相比)、血管活性药物的使用、呼吸机的使用以及简化急性生理学评分(SAPS)II与生存差异相关。由于急性肾损伤病因(心脏或肝衰竭),存活后需要维持性透析的比例较高(80.1%[29/36])。代谢及液体控制率为77.3%。急性腹膜透析的技术成功率为93.3%。

结论

在连续性肾脏替代治疗(CRRT)时代,急性腹膜透析仍是急性肾损伤患者的合适治疗方式。几乎所有需要透析的患者都可以进行急性腹膜透析,且无机械困难。对于难治性心力衰竭和急性胰腺炎且对血管活性药物需求较低的患者尤其如此。

相似文献

1
Acute Peritoneal Dialysis in Patients with Acute Kidney Injury.急性肾损伤患者的急性腹膜透析
Perit Dial Int. 2017 Sep-Oct;37(5):529-534. doi: 10.3747/pdi.2016.00264. Epub 2017 Mar 27.
2
Acute Kidney Injury in Critically Ill Patients: A Prospective Randomized Study of Tidal Peritoneal Dialysis Versus Continuous Renal Replacement Therapy.危重症患者的急性肾损伤:潮式腹膜透析与连续性肾脏替代治疗的前瞻性随机研究
Ther Apher Dial. 2018 Aug;22(4):371-379. doi: 10.1111/1744-9987.12660. Epub 2018 Mar 25.
3
The impact of continuous renal replacement therapy on renal outcomes in dialysis-requiring acute kidney injury may be related to the baseline kidney function.持续肾脏替代疗法对需要透析的急性肾损伤患者肾脏预后的影响可能与基线肾功能有关。
BMC Nephrol. 2017 May 3;18(1):150. doi: 10.1186/s12882-017-0564-z.
4
High volume peritoneal dialysis vs daily hemodialysis: a randomized, controlled trial in patients with acute kidney injury.大容量腹膜透析与每日血液透析:急性肾损伤患者的一项随机对照试验。
Kidney Int Suppl. 2008 Apr(108):S87-93. doi: 10.1038/sj.ki.5002608.
5
Peritoneal dialysis in children with sepsis-associated AKI (SA-AKI): an experience in a low- to middle-income country.儿童脓毒症相关性急性肾损伤(SA-AKI)的腹膜透析:中低收入国家的经验。
Paediatr Int Child Health. 2021 May;41(2):137-144. doi: 10.1080/20469047.2021.1874201. Epub 2021 Jan 17.
6
Intermittent peritoneal dialysis in acute kidney injury.急性肾损伤中的间歇性腹膜透析
J Med Assoc Thai. 2011 Sep;94 Suppl 4:S126-30.
7
Advances in peritoneal dialysis in acute kidney injury.急性肾损伤中腹膜透析的进展。
Blood Purif. 2012;34(2):107-16. doi: 10.1159/000341648. Epub 2012 Oct 24.
8
Efficacy and outcome of intermittent peritoneal dialysis in patients with acute kidney injury: A single-center experience.间歇性腹膜透析治疗急性肾损伤患者的疗效和结局:单中心经验。
Saudi J Kidney Dis Transpl. 2020 Mar-Apr;31(2):423-430. doi: 10.4103/1319-2442.284017.
9
Intensive Versus Minimal Standard Dosage for Peritoneal Dialysis in Acute Kidney Injury: A Randomized Pilot Study.急性肾损伤腹膜透析的强化与最低标准剂量:一项随机试点研究
Perit Dial Int. 2017 Sep-Oct;37(5):523-528. doi: 10.3747/pdi.2016.00260. Epub 2017 May 25.
10
New experiences with the therapy of acute kidney injury.急性肾损伤治疗的新经验。
Prilozi. 2008 Dec;29(2):119-53.

引用本文的文献

1
Is It Time to Give Peritoneal Dialysis Its Due Place in Managing Acute Kidney Injury: Lessons Learnt from COVID-19 Pandemic.是时候让腹膜透析在急性肾损伤管理中发挥应有的作用了:从 COVID-19 大流行中吸取的教训。
Blood Purif. 2024;53(2):71-79. doi: 10.1159/000535243. Epub 2023 Nov 17.
2
Urgent Implantation of Peritoneal Dialysis Catheter in Chronic Kidney Disease and Acute Kidney Injury-A Review.慢性肾脏病和急性肾损伤中腹膜透析导管的紧急植入——综述
J Clin Med. 2023 Aug 2;12(15):5079. doi: 10.3390/jcm12155079.
3
Percutaneous insertion of peritoneal dialysis catheter is a safe and effective technique irrespective of BMI.
经皮穿刺腹膜透析置管术是一种安全有效的技术,与 BMI 无关。
BMC Nephrol. 2020 May 25;21(1):199. doi: 10.1186/s12882-020-01850-5.
4
Vancomycin Removal During High-Volume Peritoneal Dialysis in Acute Kidney Injury Patients: A Prospective Cohort Clinical Study.
Kidney Int Rep. 2018 Sep 27;4(1):112-118. doi: 10.1016/j.ekir.2018.09.014. eCollection 2019 Jan.